Carboxylated chitooligosaccharides (CCOS) inhibit MMP-9 expression in human fibrosarcoma cells via down-regulation of AP-1

Biochimica et Biophysica Acta - General Subjects

Volumn 1760, Issue 12, 2006, Pages 1780-1788

  Rajapakse, Niranjan ^a   Kim, Moon Moo ^a   Mendis, Eresha ^a   Huang, Ronghua ^b   Kim, Se Kwon ^a  

^a Pukyong National University   (South Korea)

^b WUHAN UNIVERSITY   (China)

Author keywords

Activator protein 1 (AP 1); Carboxylated chitooligosaccharide (CCOS); Matrix metalloproteinase 9 (MMP 9); Transcriptional regulation

Indexed keywords

CARBOHYDRATE DERIVATIVE; CARBOXYLATED CHITOOLIGOSACCHARIDE 1; CARBOXYLATED CHITOOLIGOSACCHARIDE 2; CARBOXYLATED CHITOOLIGOSACCHARIDE 3; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NUCLEAR PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; DOSE RESPONSE; DOWN REGULATION; DRUG POTENCY; DRUG SCREENING; DRUG SYNTHESIS; ENZYME ACTIVITY; ENZYME INHIBITION; FIBROSARCOMA; GENE CONSTRUCT; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; NUCLEOTIDE SEQUENCE; ONCOGENE C FOS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REPORTER GENE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; ZYMOGRAPHY;

BLOTTING, WESTERN; CARBOHYDRATE CONFORMATION; CELL LINE, TUMOR; DOWN-REGULATION; FIBROSARCOMA; HUMANS; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; OLIGOSACCHARIDES; PROTEASE INHIBITORS; TRANSCRIPTION FACTOR AP-1;

EID: 33750611730     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2006.08.021     Document Type: Article

References (26)

1. Sato H., Takino T., Okada Y., Cao J., Shinagawa A., Yamamoto E., and Seiki M. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370 (1994) 61-65
2. Woessner F.J., and Nagase H. Matrix Metalloproteinases and TIMPs (2000), Oxford University Press New York
3. Xue M., Le N.T., and Jacksn C.J. Targeting matrix metalloproteases to improve cutaneous wound healing. Expert Opin. Ther. targets 10 (2006) 143-155
4. Tanimura S., Kadomoto R., Tanaka T., Zhang Y.J., Kouno I., and Kohno M. Suppression of tumor cell invasiveness by hydrolysable tannins (plant polyphenols) via the inhibition of matrix metalloproteinase-2/-9 activity. Biochem. Biophys. Res. Commun. 330 (2005) 1306-1313
5. Malemud C.J. Matrix metalloproteinases (MMPs) in health and disease: an overview. Front. Biosci. 11 (2006) 1696-1701
6. Jiang Y., and Muschel R.J. Regulation of matrix metalloproteinase-9 (MMP-9) by translational efficiency in murine prostate carcinoma cells. Cancer Res. 62 (2002) 1910-1914
7. Sato H., Kida Y., Mai M., Endo Y., Tanaka J., and Seiki M. Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells. Oncogene 7 (1992) 77-83
8. Moon S.K., Kim H.M., and Kim C.H. PTEN induces G1 cell cycle arrest and inhibits MMP-9 expression via the regulation of NF-kappaB and AP-1 in vascular smooth muscle cells. Arch. Biochem. Biophys. 421 (2004) 267-276
9. Sato T., Koike L., Miyata Y., Hirata M., Mimaki Y., Sashida Y., Yano M., and Ito A. Inhibition of activator protein-1 binding activity and phosphatidylinositol 3-kinase pathway by nobiletin, a polymethoxy flavonoid, results in augmentation of tissue inhibitor of metalloproteinases-1 production and suppression of production of matrix metalloproteinases-1 and-9 in human fibrosarcoma HT-1080 Cells. Cancer Res. 62 (2002) 1025-1029
10. Heidinger M., Kolb H., Krell H.W., Jochum M., and Ries C. Modulation of autocrine TNF-alpha-stimulated matrix metalloproteinase 9 (MMP-9) expression by mitogen-activated protein kinases in THP-1 monocytic cells. Biol. Chem. 387 (2006) 69-78
11. Kim S.K., and Rajapakse N. Enzymatic production and biological activities of chitosan oligosaccharides (COS): A review. Carbohydr. Polym. 62 (2005) 357-368
12. Huang R., Rajapakse N., and Kim S.K. Structural factors affecting radical scavenging activity of chitooligosaccharides (COS) and its derivatives. Carbohydr. Polym. 63 (2006) 122-129
13. Hansen M.B., Nielsen S.E., and Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods 119 (1989) 203-210
14. Hrabec E., Strek M., Nowak D., Greger J., Suwalski M., and Hrabec Z. Activity of type IV collagenases (MMP-2 and MMP-9) in primary pulmonary carcinomas: a quantitative analysis. J. Cancer Res. Clin. Oncol. 128 (2002) 197-204
15. Netzel-Arnett S., Mallya S.K., Nagase H., Birkedal-Hansen H., and Van Wart H.E. Continuously recording fluorescent assays optimized for five human matrix metalloproteinases. Anal. Biochem. 195 (1991) 86-92
16. Lin C.W., and Lin J.C. Characterization and blood coagulation evaluation of the water-soluble chitooligosaccharides prepared by a facile fractionation method. Biomacromolecules 4 (2003) 1691-1697
17. Muzzarelli R.A.A. Human enzymatic activities related to the therapeutical administration of chitin derivatives. Cell. Mol. Life Sci. 53 (1997) 131-140
18. Ronghua H., Yumin D., and Jianhong Y. Preparation and in vitro anticoagulant activities of alginate sulfate and its quaterized derivatives. Carbohydr. Polym. 52 (2003) 19-24
19. Ronghua H., Yumin D., and Jianhong Y. Preparation and anticoagulant activity of carboxybutyrylated hydroxyethyl chitosan sulfates. Carbohydr. Polym. 51 (2003) 431-438
20. Mao S., Shuai X., Unger F., Simon M., Bi D., and Kissel T. The depolymerization of chitosan: effects on physicochemical and biological properties. Int. J. Pharm. 281 (2004) 45-54
21. Rodriguez-Salvador J., Armas-Pineda C., Perezpena-Diazconti M., Chico-Ponce de Leon F., Sosa-Sainz G., Lezama P., Recillas-Targa F., and Arenas-Huertero F. Effect of sodium butyrate on pro-matrix metalloproteinase-9 and-2 differential secretion in pediatric tumors and cell lines. J. Exp. Clin. Cancer Res. 24 (2005) 463-473
22. 2 activates pro-matrix metalloproteinase-2 through receptor tyrosine kinase/phosphatidylinositol 3-kinase/NF- κB pathway. J. Biol. Chem. 277 (2002) 30271-30282
23. Tessone A., Feinberg M.S., Barbash I.M., Reich R., Holbova R., Richmann M., Mardor Y., and Leor J. Effect of matrix metalloproteinase inhibition by doxycycline on myocardial healing and remodeling after myocardial infarction. Cardiovasc. Drugs Ther. 19 (2005) 383-390
24. Takahra T., Smart D.E., Oakley F., and Mann D.A. Induction of myofibroblast MMP-9 transcription in three-dimensional collagen I gel cultures: regulation by NF-kappaB, AP-1 and Sp1. Int. J. Biochem. Cell Biol. 36 (2004) 353-363
25. Yan C., Wang H., and Boyd D.D. KiSS-1 represses 92-kDa type IV collagenase expression by down-regulating NF-kappa B binding to the promoter as a consequence of Ikappa B alpha-induced block of p65/p50 nuclear translocation. J. Biol. Chem. 276 (2001) 1164-1172
26. Liotta L.A., and Stetler-Stevenson W.G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64 (1991) 327-336